Patents by Inventor Kari Ohlsen

Kari Ohlsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070031814
    Abstract: Methods are provided for identifying agents that modulate intracellular calcium. Also provided are methods of modulating calcium within cells and methods of identifying proteins involved in modulating intracellular calcium.
    Type: Application
    Filed: March 3, 2004
    Publication date: February 8, 2007
    Inventors: Jack Roos, Kenneth Stauderman, Gonul Velicelebi, Paul Digregorio, Kari Ohlsen
  • Publication number: 20030181408
    Abstract: The sequences of nucleic acids encoding proteins required for E. coli proliferation are disclosed. The nucleic acids can be used to express proteins or portions thereof, to obtain antibodies capable of specifically binding to the expressed proteins, and to use those expressed proteins as a screen to isolate candidate molecules for rational drug discovery programs. The nucleic acids can also be used to screen for homologous genes that are required for proliferation in microorganisms other than E. Coli. The nucleic acids can also be used to design expression vectors and secretion vectors. The nucleic acids of the present invention can also be used in various assay systems to screen for proliferation required genes in other organisms as well as to screen for antimicrobial agents.
    Type: Application
    Filed: October 31, 2002
    Publication date: September 25, 2003
    Inventors: R. Allyn Forsyth, Kari Ohlsen, Judith W. Zyskind
  • Patent number: 6589738
    Abstract: The sequences of nucleic acids encoding proteins required for E. Coli proliferation are disclosed. The nucleic acids can be used to express proteins or portions thereof, to obtain antibodies capable of specifically binding to the expressed proteins, and to use those expressed proteins as a screen to isolate candidate molecules for rational drug discovery programs. The nucleic acids can also be used to screen for homologous genes that are required for proliferation in microorganisms other than E. Coli. The nucleic acids can also be used to design expression vectors and secretion vectors. The nucleic acids of the present invention can also be used in various assay systems to screen for proliferation required genes in other organisms as well as to screen for antimicrobial agents.
    Type: Grant
    Filed: November 9, 2000
    Date of Patent: July 8, 2003
    Assignee: Elitra Pharmaceuticals, Inc.
    Inventors: R. Allyn Forsyth, Kari Ohlsen, Judith W. Zyskind